AETHLON MEDICAL INC AEMD Cash Flow

Aethlon medical inc (AEMD)

CashFlow / TTM

Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11
Cash flows used in operating activities:
NET LOSS
-6,240	-7,438	-7,134	-6,219	-5,899	-5,100	-5,006	-5,699	-6,066	-6,060	-7,015	-7,306	-6,870	-6,890	-5,878	-4,958	-4,629	-4,855	-4,491	-6,979	-13,569	-14,378	-16,839	-13,438	0	0	0	-	-	-	-	-	-	-	-
Net income (loss)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-6,622	-7,511	-6,542	-8,111	0	0	0
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization
21	20	25	30	33	33	34	35	33	30	31	32	0	0	0	-	-	-	-	-	-	-	-	21	16	9	10	10	11	12	15	17	0	0	0
Gain on debt conversion
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0
Stock based compensation
1,130	1,372	1,382	1,319	1,317	1,295	1,243	1,260	1,193	1,176	2,416	2,186	1,930	1,675	202	202	230	257	296	416	0	0	0	-	-	560	711	765	720	706	704	758	0	0	0
Change in fair value of derivative liabilities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	617	1,926	571	766	0	0	0
Loss on debt extinguishment
-447	-447	-447	0	0	0	0	-376	-376	-318	-318	-558	-558	-616	-616	0	0	-222	-300	-2,753	0	0	0	-	-	-	0	-	-	-	-	-	-	-	-
Warrant repricing expense
-	-	-	-	-	-	-	-	-	-	-	345	345	345	345	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
(Gain) on share for warrant exchanges
-	-	-	-	-	-	-	-130	-130	-130	-119	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Amortization of debt discount
0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accretion of right-of-use asset
-	-	0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Loss on settlement of notes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-
Amortization of debt discount and deferred financing costs
-	-	-	-	-	-	-	245	370	358	347	220	222	338	432	517	502	477	375	273	131	22	12	5	13	16	113	594	1,481	1,658	2,039	2,598	0	0	0
Depreciation and amortization
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Loss on settlement of convertible note termination
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	360	0	0	0
Liquidated damages
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0
Common stock issued for services
-	-	-	-	-	-	-	33	33	33	33	0	0	0	0	-	-	-	-	225	352	290	408	392	337	384	156	259	199	230	258	341	0	0	0
Par value of shares issued for repurchase of vested restricted stock units
-	-	0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income taxes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0
Conversion of debt, accrued liabilities and accrued interest to common stock
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2,273	2,292	1,313	1,386	726	0	0	0	-	-	2,100	1,629	2,058	0	0	0
Reclassification of note payable to convertible note payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-
Reclassification of warrant derivative liability into equity
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	45	58	74	280	289	0	0	0
Debt discount on notes payable associated with embedded conversion feature and detachable warrants
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,362	0	0	0
Reclassification of accrued interest to convertible notes payable
-	-	-	-	-	-	-	-	-	-	-	85	85	85	85	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Issuance of shares under vested restricted stock units
-	-	-	-	-	-	-	-	-	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Reclassification of warrant derivative liability into equity
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,456	0	0	0	-	-	-	-	-	-	-	-
Debt discount on convertible notes payable
-	-	-	-	-	-	-	-	-	-	950	783	863	75	75	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Reclassification of note payable to convertible notes payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0
Non-cash rent expense
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	11	167	167	167	694	0	0	0
Changes in operating assets and liabilities:
Accounts receivable
-	-	-	-	-	-	-	-	-	-	-	-199	-1	6	-0	6	-13	-70	-10	98	-29	37	11	-113	-755	-580	-800	-191	183	0	0	-400	0	0	0
Prepaid expenses and other current assets
11	25	9	28	14	-3	104	143	-17	25	15	-15	-150	-43	-70	-19	135	67	51	22	20	-13	8	21	25	55	35	-1	-43	-52	-19	-1	0	0	0
Interest receivable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0
Accounts payable and other current liabilities
-272	615	339	390	507	-37	83	-104	51	1	-16	322	138	224	52	-46	-465	-1,416	-1,249	-1,108	-1,998	243	-24	46	1,583	421	799	751	627	839	1,002	920	0	0	0
Due to related parties
41	2	4	-6	5	50	42	32	6	-9	20	-87	-96	-145	-146	-1	-655	-684	-642	-692	38	74	32	116	50	107	78	6	116	102	63	112	0	0	0
Net cash used in operating activities
-4,974	-4,804	-4,722	-4,293	-3,913	-3,617	-3,654	-3,910	-3,846	-3,845	-3,752	-3,505	0	0	0	-	-	-	-	-	-	-	0	-	-	-	-	-2,098	-2,317	-1,720	-1,621	-1,841	0	0	0
Net cash used in operating activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-
Cash flows from investing activities:
Purchases of property and equipment
148	119	0	0	1	1	1	24	37	37	38	16	2	12	10	9	0	0	0	-	-	-	-	-	-	-	-	0	0	0	0	1	0	0	0
Net cash used in investing activities
-148	-119	-0	0	-1	-1	-1	-24	-37	-37	-38	-16	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	-1	0	0	0
Net cash used in investing activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash flows provided by (used in) financing activities:
Proceeds from collection of secured notes receivable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	200	0	0	0
Proceeds from the issuance of common stock, net, value
0	0	0	-	0	0	0	-	-	-	0	-	-	-	-	-	5,606	9,684	10,034	4,763	4,765	3,619	3,369	3,177	3,713	1,264	1,435	2,109	1,871	1,373	1,102	300	0	0	0
Principal payments on convertible notes
0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Tax withholding payments or tax equivalent payments for net share settlement of restricted stock units
0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash paid for repurchase of restricted stock units
-	-	-	-	-	-	-	-	-	-	514	378	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Principal repayments of notes payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	29	237	247	252	223	0	0	0
Proceeds from the issuance of convertible notes payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,694	0	0	0
Net proceeds from the issuance of common stock and exercise of warrants
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net provided by financing activities
4,356	631	1,093	1,147	3,129	7,776	9,451	9,349	8,866	4,246	2,824	2,958	0	0	0	-	-	-	-	-	-	-	0	-	-	-	-	2,080	2,070	1,947	2,203	1,971	0	0	0
Net cash provided by financing activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-
Net decrease in cash
-	0	-3,630	-	-	4,158	5,795	5,414	4,982	363	-967	-564	-2,622	-3,653	-4,355	1,268	0	0	0	-	-	517	775	1,125	1,746	-262	-564	-18	-246	226	582	128	0	0	0
Supplement disclosures of cash flow information:
Interest
83	83	167	95	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	13	13	2	2	2	28	29	32	29	0	0	0
Income taxes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	-	-	-	-
Supplemental information of non-cash investing and financing activities:
Initial recognition of right-of-use lease asset and lease liability
0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-